From antibacterial to antitumour agents: a brief review on the chemical and medicinal aspects of sulfonamides

H Azevedo-Barbosa, DF Dias, LL Franco… - Mini Reviews in …, 2020 - ingentaconnect.com
Sulfonamides have been in clinical use for many years, and the development of bioactive
substances containing the sulfonamide subunit has grown steadily in view of their important …

[HTML][HTML] Advances in cancer therapy: A comprehensive review of CDK and EGFR inhibitors

M Hawash - Cells, 2024 - mdpi.com
Protein kinases have essential responsibilities in controlling several cellular processes, and
their abnormal regulation is strongly related to the development of cancer. The …

Advances in synthesis and biological evaluation of CDK2 inhibitors for cancer therapy

DA Patel, SS Patel, HD Patel - Bioorganic Chemistry, 2024 - Elsevier
One of the leading causes of mortality in the world is cancer. This disease occurs when
responsible genes that regulate the cell cycle become inactive due to internal or external …

Mechanistic selectivity investigation and 2D-QSAR study of some new antiproliferative pyrazoles and pyrazolopyridines as potential CDK2 inhibitors

GS Hassan, HH Georgey, EZ Mohammed… - European Journal of …, 2021 - Elsevier
Novel series of diphenyl-1H-pyrazoles (4a-g) and pyrazolo [3, 4-b] pyridines (5a-g and 7a-i)
were synthesized and evaluated for their antiproliferative activity against breast cancer cell …

A comprehensive insight on the recent development of cyclic dependent kinase inhibitors as anticancer agents

BN Marak, J Dowarah, L Khiangte, VP Singh - European Journal of …, 2020 - Elsevier
Cancer is one of the major leading causes of death worldwide despite many breakthroughs
in the development of novel anticancer drugs. The heterodimer CDK-Cyclin complex plays …

Design, synthesis, anticancer evaluation and molecular docking study of novel 2, 4-dichlorophenoxymethyl-based derivatives linked to nitrogenous heterocyclic ring …

AA El-Sayed, ES Nossier, AA Almehizia… - Journal of Molecular …, 2022 - Elsevier
Abstract A novel series of 2, 4-dichlorophenoxymethyl-based derivatives 4-18 bearing
various nitrogenous heterocyclic systems have been designed and synthesized through …

Synthesis, in vitro anticancer activity and in silico studies of certain pyrazole-based derivatives as potential inhibitors of cyclin dependent kinases (CDKs)

EZ Mohammed, WR Mahmoud, RF George… - Bioorganic …, 2021 - Elsevier
New diphenyl-1H-pyrazoles were synthesized and screened for CDK2 inhibition where 8d,
9b, 9c, and 9e exhibited promising activity (IC 50= 51.21, 41.36, 29.31, and 40.54 nM …

Structural characterization and molecular docking screening of most potent 1, 2, 4-triazine sulfonamide derivatives as anti-cancer agents

S Mutahir, MA Khan, AM Naglah, MA Al-Omar… - Crystals, 2023 - mdpi.com
One of the biggest problems facing contemporary medicine is cancer. New approaches to
therapy are required due to the difficult and prolonged treatment, the numerous adverse …

Discovery of pyridine-sulfonamide hybrids as a new scaffold for the development of potential VEGFR-2 inhibitors and apoptosis inducers

MF Ahmed, EY Santali - Bioorganic Chemistry, 2021 - Elsevier
New sulfonamide derivatives have been synthesized and tested as antitumor agents. All
newly synthesized compounds were tested in vitro against 60 lines of human cancer cells …

To control or to be controlled? Dual roles of CDK2 in DNA damage and DNA damage response

Q Liu, J Gao, C Zhao, Y Guo, S Wang, F Shen, X Xing… - DNA repair, 2020 - Elsevier
Abstract CDK2 (cyclin-dependent kinase 2), a member of the CDK family, has been shown
to play a role in many cellular activities including cell cycle progression, apoptosis and …